["The neuronal ceroid lipofuscinoses (NCLs) are at least 13 distinct progressive neurodegenerative disorders unified by the accumulation of lysosomal auto-fluorescent material called lipofuscin. The only form that occurs via autosomal-dominant inheritance exhibits adult onset and is sometimes referred to as Parry type NCL. The manifestations may include behavioral symptoms followed by seizures, ataxia, dementia, and early death. Mutations in the gene DNAJC5 that codes for the presynaptic co-chaperone cysteine string protein-\u03b1 (CSP\u03b1) were recently reported in sporadic adult-onset cases and in families with dominant inheritance. The mutant CSP\u03b1 protein may lead to disease progression by both loss and gain of function mechanisms. Iron chelation therapy may be considered as a possible pharmaceutical intervention based on our recent mechanism-based proposal of CSP\u03b1 oligomerization via ectopic Fe-S cluster-binding, summarized in this review.",{"copyright":"\u00a9 2020 John Wiley & Sons A\/S. Published by John Wiley & Sons Ltd."}]
Address:
Appel Institute for Alzheimer's Disease Research, and Brain & Mind Research Institute, Weill Cornell Medicine, New York City, New York, USA.; New York State Institute for Basic Research in Developmental Disabilities, Staten Island, New York, USA.
NED wishes to thank the following organisations for their support:
We use cookies to improve your experience and analyze site traffic with Google Analytics. By continuing to use our site, you agree to our use of cookies. Learn more.